Anaesthesia
Final Professional MBBS — Anaesthesiology. Explanation-first answers covering the principles and conduct of anaesthesia, the anaesthesia machine, airway, drugs, regional techniques, monitoring, fluids, complications and resuscitation, with classifications, comparison tables, drug doses, clinical pearls and key-point recaps from Morgan & Mikhail and Miller's Anesthesia.
Definition & Role
Inhalational (volatile) anaesthetic agents are drugs given as a gas or vapour that, when inhaled, produce and maintain general anaesthesia. They are mainly used for the maintenance of anaesthesia (and for inhalational induction, especially in children), delivered by a vaporiser through the breathing system. Their effect is titrated by adjusting the inspired concentration.
Properties of the Ideal Agent
An ideal inhalational agent would be: potent yet allow a high inspired oxygen; have low blood–gas solubility (rapid onset and offset); be pleasant and non-irritant to inhale (smooth induction); chemically stable and non-flammable; produce minimal cardiovascular and respiratory depression; undergo minimal metabolism (few toxic products); not trigger malignant hyperthermia; be cheap; and be environmentally friendly. No agent is ideal; each is a compromise.
Potency & MAC
Potency is expressed by the minimum alveolar concentration (MAC) — the alveolar concentration preventing movement to a standard surgical stimulus in 50% of subjects. A low MAC = high potency. MAC values are roughly additive (e.g. nitrous oxide plus a volatile agent), the basis of using agents in combination to reduce the dose — and side-effects — of each.
Agent MAC (%) Blood–gas coefficient Note Nitrous oxide ~104 0.47 Weak; analgesic; carrier & second-gas effect Halothane 0.75 2.4 Potent; soluble (slow); hepatitis; arrhythmias Isoflurane 1.15 1.4 Stable; can irritate airway Sevoflurane 2.0 0.65 Non-irritant — inhalational induction Desflurane 6.0 0.42 Fastest on/off; pungent (not for induction) 💡Two numbers summarise a volatile agent: MAC (potency — lower is more potent) and the blood–gas partition coefficient (speed — lower is faster on and off). Sevoflurane’s non-irritant nature makes it the agent for gaseous induction; desflurane’s very low solubility makes it the fastest.Mechanism (Brief)
The precise mechanism is incompletely understood, but volatile agents are thought to act by enhancing inhibitory (GABA_A, glycine) and depressing excitatory neurotransmission in the central nervous system, producing dose-dependent depression of consciousness. Their effect correlates with lipid solubility (the historical Meyer–Overton correlation).
Advantages of the Inhalational Route
The inhalational route has properties that keep it central to anaesthetic practice. Because the agent is continuously delivered to and eliminated from the lungs, its effect can be titrated up and down breath by breath, and the depth of anaesthesia can be monitored directly by measuring the end-tidal agent concentration — a real advantage over a drug committed to the circulation by injection. Elimination is largely by the lungs and is relatively independent of the liver and kidneys, which is useful in patients with organ impairment, and the volatile agents also provide a degree of muscle relaxation and, in the case of nitrous oxide, analgesia. These features explain why, despite the popularity of intravenous techniques, inhalational maintenance remains a mainstay.
Measuring & Delivering the Agent
In modern practice the anaesthetist does not guess the depth of a volatile anaesthetic but measures the end-tidal agent concentration, displayed by the gas analyser in both percentage and MAC-multiple terms, and titrates the vaporiser to keep it in the desired range — typically around 1–1.3 MAC (allowing for any nitrous oxide or opioid) to balance adequate depth against cardiovascular depression. The agent is delivered from an agent-specific vaporiser into the breathing system, and the inspired oxygen concentration is monitored simultaneously so that a high vapour concentration is never delivered at the expense of oxygenation. This combination of accurate delivery and end-tidal monitoring is what makes inhalational anaesthesia so controllable and is central to preventing both awareness and overdose.
Depth depends on brain partial pressure, not inspired concentration. 🔑KEY POINTS TO REMEMBER- Volatile agents are inhaled vapours for maintenance (and gaseous induction) of anaesthesia.
- Ideal agent: potent, low solubility (fast), non-irritant, stable, minimal depression/metabolism, cheap — none is ideal.
- Potency = MAC (low MAC = potent); MAC values additive.
- Speed = blood–gas solubility (low = fast on/off).
- Act by enhancing inhibitory & depressing excitatory CNS transmission (correlates with lipid solubility).
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Overview
The speed of induction and recovery with an inhalational agent depends on how quickly the alveolar (and hence brain) partial pressure of the agent rises towards the inspired concentration — expressed as the ratio F_A/F_I. The faster this ratio approaches 1, the faster the onset. The single most important determinant is the agent’s blood–gas solubility.
The alveolar concentration (F_A/F_I) rises fastest for low-solubility agents (desflurane, nitrous oxide) and slowest for soluble agents (halothane) — so low solubility means faster induction and recovery. Blood–Gas Solubility
A low blood–gas partition coefficient means the agent is relatively insoluble in blood: the blood is quickly ‘saturated’, so the alveolar (and arterial) partial pressure rises rapidly and equilibrates with the brain — giving fast induction and fast recovery (e.g. desflurane 0.42, nitrous oxide 0.47, sevoflurane 0.65). A soluble agent (halothane 2.4) is taken up avidly by blood, so the alveolar partial pressure rises slowly — slow onset and offset.
Other Factors
The rate of rise is also increased by a high inspired concentration (the concentration effect), a high alveolar ventilation (faster delivery), and a low cardiac output (less agent carried away). Delivering a second gas alongside a rapidly-absorbed first gas (nitrous oxide) speeds the second’s uptake — the second gas effect. Agent, patient and equipment factors interact to determine the actual speed.
💡Low blood–gas solubility → fast onset and offset. Counter-intuitively, a low cardiac output speeds inhalational induction (less agent is removed from the alveoli), whereas it slows an intravenous induction — a favourite exam point.Clinical Relevance
These principles explain why sevoflurane and desflurane give rapid, controllable anaesthesia and quick recovery, why halothane is slow, and why increasing the vaporiser setting and ventilation speeds deepening. Understanding uptake also underlies safe use of low-flow anaesthesia.
Recovery & Context-Sensitivity
The same principles that govern induction also govern recovery: when the vaporiser is turned off, the agent moves back from brain to blood to alveoli to be exhaled, and the process is fastest for the least soluble agents, so desflurane and sevoflurane allow a rapid, predictable wake-up while halothane is slow. Recovery from a very long anaesthetic is a little slower for the more soluble agents because tissues such as fat act as a reservoir that continues to release agent after the vaporiser is off — a context-sensitivity that favours the insoluble agents for prolonged surgery and for patients in whom a rapid return of airway reflexes is important.
💡Two counter-intuitive exam points about uptake: a low cardiac output speeds an inhalational induction (less agent is carried away from the alveoli, so the alveolar concentration rises faster), the opposite of its effect on an intravenous induction; and increasing alveolar ventilation speeds the induction most for the more soluble agents.🔑KEY POINTS TO REMEMBER- Speed depends on how fast alveolar concentration (F_A/F_I) rises → governed by blood–gas solubility.
- Low solubility (desflurane, N₂O, sevoflurane) = fast on/off; soluble (halothane) = slow.
- Also faster with high inspired concentration (concentration effect), high ventilation, low cardiac output.
- Second gas effect: N₂O’s rapid uptake speeds a co-administered volatile.
- Explains rapid, controllable modern agents & underlies low-flow anaesthesia.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Overview
Several volatile agents are in use, each a compromise between the ideal properties. They are compared by potency (MAC), speed (blood–gas solubility), airway irritancy, cardiovascular/respiratory effects, metabolism and specific toxicities.
Agent Key features Sevoflurane Non-irritant → inhalational induction; low solubility (fast); little arrhythmia Isoflurane Stable, potent; airway irritant; useful, inexpensive maintenance agent Desflurane Lowest solubility (fastest on/off); very pungent (not for induction); needs a heated vaporiser Halothane Potent, non-irritant; soluble (slow); arrhythmias & halothane hepatitis (now little used) Nitrous oxide Weak, analgesic carrier gas; second-gas & concentration effects; diffusion hypoxia Sevoflurane & Desflurane
Sevoflurane is non-irritant, pleasant to breathe and of low solubility, making it the agent of choice for inhalational induction (especially in children) and for smooth, rapidly-controllable maintenance. Desflurane has the lowest blood–gas solubility (fastest onset/offset, useful for prolonged surgery and obese patients) but is pungent (causing coughing/laryngospasm, so unsuitable for induction) and needs a special heated vaporiser.
Isoflurane & Halothane
Isoflurane is a stable, potent, economical maintenance agent that can irritate the airway and causes dose-dependent vasodilatation. Halothane is potent and non-irritant (once popular for induction) but is soluble (slow), sensitises the myocardium to catecholamines (arrhythmias), and is associated with halothane hepatitis — so it is now largely replaced by newer agents (though still used in some settings for cost reasons).
💡Match the agent to the task: sevoflurane for gaseous induction (non-irritant), desflurane for the fastest recovery (lowest solubility, but pungent), isoflurane as a cheap maintenance agent, and remember halothane for its classic hazards (arrhythmias, hepatitis).⚠️Halothane sensitises the heart to catecholamines — avoid or use adrenaline cautiously (e.g. in infiltration) during halothane anaesthesia, as it can precipitate ventricular arrhythmias.Environmental & Practical Considerations
Beyond their clinical effects, the volatile agents differ in ways that increasingly influence choice: they are greenhouse gases of differing potency (desflurane and nitrous oxide having a particularly high global-warming impact), which is driving interest in low-flow techniques and in reducing desflurane and nitrous-oxide use; and they differ in cost and in the equipment they need, desflurane requiring a specially heated, pressurised vaporiser because of its low boiling point. Metabolism also varies — halothane is extensively metabolised, sevoflurane modestly, and desflurane and isoflurane very little — which correlates with their potential for metabolite-related toxicity.
💡A quick way to rank the agents: for speed desflurane > sevoflurane > isoflurane > halothane (by rising solubility); for gaseous induction only the non-irritant sevoflurane (and historically halothane) is suitable; and for classic hazards remember halothane’s arrhythmias and hepatitis and every potent volatile’s ability to trigger malignant hyperthermia.⚠️Halothane’s two dangers must be remembered together: it sensitises the myocardium to catecholamines, so exogenous adrenaline (even in surgical infiltration) can precipitate ventricular arrhythmias, and it carries the risk of halothane hepatitis on repeated exposure — which is why, where alternatives exist, the newer agents are preferred and halothane is not repeated within a short interval.💡For an exam answer, name each agent by its defining characteristic: sevoflurane the non-irritant induction agent, desflurane the fastest but pungent one, isoflurane the cheap stable maintenance agent, and halothane the potent but arrhythmogenic and hepatotoxic relic — with nitrous oxide the weak analgesic carrier gas.Sevoflurane is non-irritant, hence used for gas induction. 🔑KEY POINTS TO REMEMBER- Agents compared by MAC, solubility, irritancy, CVS/RS effects, metabolism, toxicity.
- Sevoflurane: non-irritant, low solubility → inhalational induction & smooth maintenance.
- Desflurane: lowest solubility (fastest) but pungent (not for induction); heated vaporiser.
- Isoflurane: stable, cheap maintenance, airway irritant; halothane: soluble, arrhythmias, hepatitis.
- Halothane sensitises myocardium to catecholamines — caution with adrenaline.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Properties
Nitrous oxide (N₂O) is a colourless, sweet-smelling gas that is a weak anaesthetic but a good analgesic. Its MAC is very high (~104%), so it cannot be used alone at safe (non-hypoxic) concentrations; instead it is used as a carrier and adjunct — typically up to ~70% with oxygen — to supplement a volatile or intravenous agent, reducing the dose needed (MAC-sparing).
Useful Effects
Because it is taken up rapidly, N₂O produces the concentration and second-gas effects that speed inhalational induction, and it contributes analgesia and some hypnosis. A 50:50 mixture with oxygen (Entonox) is used for analgesia in labour, ambulance care and short painful procedures.
Adverse Effects
Diffusion hypoxia: at the end of anaesthesia, N₂O floods out of the blood into the alveoli, diluting alveolar oxygen — so 100% oxygen is given on discontinuation to prevent hypoxia. Expansion of air-filled spaces: being far more soluble than nitrogen, N₂O diffuses into and expands closed gas spaces (pneumothorax, bowel obstruction, middle ear, gas emboli, the tracheal-tube cuff) — so it is avoided in these situations. Bone-marrow/neurological toxicity: N₂O inactivates vitamin B₁₂ (inhibits methionine synthase), so prolonged/repeated exposure can cause megaloblastic anaemia and neuropathy.
⚠️Avoid nitrous oxide when there is a closed air space — pneumothorax, bowel obstruction, air embolism, middle-ear or intra-ocular gas — because it diffuses in and expands the space dangerously. And give 100% oxygen at the end to prevent diffusion hypoxia.💡Remember N₂O’s three classic hazards: diffusion hypoxia (give 100% O₂ at the end), expansion of closed air spaces (avoid with pneumothorax/bowel obstruction), and vitamin B₁₂ inactivation (megaloblastic anaemia/neuropathy with prolonged use).Cardiovascular & Other Effects
Unlike the potent volatile agents, nitrous oxide causes relatively little direct cardiovascular or respiratory depression and even mild sympathetic stimulation, which is one reason it has been valued as a carrier gas that allows the dose of the more depressant volatile agent to be reduced. Against these advantages must be set its inability to provide surgical anaesthesia alone, its capacity to expand air spaces and cause diffusion hypoxia, and its effect on vitamin B₁₂, together with growing environmental concerns — so its role, while still useful for analgesia and as an adjunct, has diminished in modern practice.
Historical & Current Place
Nitrous oxide is the oldest anaesthetic gas still in use, and for much of the twentieth century it was the standard carrier gas of general anaesthesia, valued for its analgesia, its MAC-sparing effect on the volatile agent and its cardiovascular stability. Its use has declined as its disadvantages have been weighed more heavily — the expansion of air spaces, diffusion hypoxia, vitamin B₁₂ inactivation with prolonged or repeated exposure, a contribution to postoperative nausea, and a substantial greenhouse-gas footprint — and as low-solubility volatile agents and intravenous techniques have provided alternatives. It nonetheless retains clear roles as an analgesic (notably as Entonox) and as a useful adjunct in appropriately selected patients.
⚠️The rule to carry from this topic is that nitrous oxide is contraindicated wherever there is a closed gas space — pneumothorax, bowel obstruction, air embolism, an intra-ocular gas bubble, middle-ear surgery or recent diving — because it diffuses in far faster than nitrogen diffuses out and dangerously expands the space; and that 100% oxygen must be given as it is discontinued to prevent diffusion hypoxia.💡Summarise nitrous oxide as weak but useful: too feeble to anaesthetise alone, but a valuable analgesic and MAC-sparing carrier — provided you respect its three hazards of air-space expansion, diffusion hypoxia and vitamin B₁₂ inactivation.Avoid in closed air spaces — it expands them. 🔑KEY POINTS TO REMEMBER- N₂O: weak anaesthetic (MAC ~104%) but good analgesic; used as a carrier/adjunct (≤ 70%) to spare MAC.
- Speeds induction (concentration & second-gas effects); Entonox (50:50) for labour/procedural analgesia.
- Diffusion hypoxia → give 100% O₂ at the end.
- Expands closed air spaces → avoid in pneumothorax, bowel obstruction, air embolism, middle-ear gas.
- Inactivates vitamin B₁₂ → megaloblastic anaemia/neuropathy with prolonged exposure.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Overview
Although modern inhalational agents are relatively safe, they share dose-dependent cardiovascular and respiratory depression and have specific toxicities. Awareness of these guides agent choice and monitoring.
Cardiovascular & Respiratory Effects
Volatile agents cause dose-dependent myocardial depression and vasodilatation (falling blood pressure), and respiratory depression (reduced tidal volume, blunted response to CO₂). Halothane notably causes bradycardia and sensitises the myocardium to catecholamines (arrhythmias); the newer agents cause less arrhythmia. All reduce the ventilatory drive, so ventilation is usually supported.
Halothane Hepatitis
Halothane hepatitis is a rare but potentially fatal immune-mediated hepatic necrosis associated with halothane, more likely after repeated exposure over a short interval, in obese middle-aged women, and with a previous unexplained reaction. It presents as fever and jaundice with markedly deranged liver function days after anaesthesia. Because of this, halothane is avoided where alternatives exist and not repeated within a short interval.
Malignant Hyperthermia
All the potent volatile agents (and suxamethonium) can trigger malignant hyperthermia in susceptible individuals — a rare, inherited, life-threatening hypermetabolic crisis of skeletal muscle (rising CO₂ production, tachycardia, rigidity, hyperthermia, acidosis) treated with dantrolene and removal of the trigger. A personal or family history mandates a trigger-free (‘clean’) anaesthetic — total intravenous anaesthesia with a vapour-free machine.
⚠️A rising end-tidal CO₂ with tachycardia, muscle rigidity and rising temperature during a volatile anaesthetic is malignant hyperthermia until proven otherwise — stop the trigger, call for help, and give dantrolene. Nitrous oxide and the intravenous agents do not trigger it.💡Group the toxicities: halothane — arrhythmias and hepatitis; all potent volatiles — malignant-hyperthermia trigger and dose-dependent cardiorespiratory depression; nitrous oxide — B₁₂ inactivation and air-space expansion (a separate profile).Postoperative Nausea & Shivering
Among the less dramatic but common adverse effects of inhalational anaesthesia are postoperative nausea and vomiting, to which the volatile agents and nitrous oxide both contribute, and postoperative shivering. These are important because they distress patients, delay recovery and discharge, and — in the case of shivering — increase oxygen consumption, which matters in patients with limited cardiorespiratory reserve. They are managed with prophylactic anti-emetics in at-risk patients, sometimes by choosing a total intravenous technique (propofol being anti-emetic), and by maintaining normothermia and using active warming to reduce shivering.
💡Organise the toxicities by agent: halothane — catecholamine-sensitised arrhythmias and immune hepatitis; all potent volatiles — dose-dependent cardiorespiratory depression and the malignant-hyperthermia trigger (treated with dantrolene); nitrous oxide — vitamin B₁₂ inactivation and air-space expansion. Nitrous oxide and the intravenous agents do not trigger malignant hyperthermia.Trigger-Free Anaesthesia
For a patient known or suspected to be susceptible to malignant hyperthermia, the entire anaesthetic is planned to be trigger-free: all potent volatile agents and suxamethonium are avoided, anaesthesia is provided by total intravenous techniques (for example propofol with a non-triggering opioid and a non-depolarising relaxant), and the anaesthetic machine is prepared to be vapour-free by removing or disabling vaporisers and flushing the circuit. Dantrolene is confirmed to be available, and the patient is monitored closely, because recognising and avoiding the triggers is far more effective than treating an established crisis.
💡The single most important adverse-effect fact is that a rising end-tidal CO₂ with tachycardia, muscle rigidity and a climbing temperature during a volatile anaesthetic signals malignant hyperthermia — stop the trigger, get help, and give dantrolene without delay.Malignant hyperthermia is triggered by all volatiles and suxamethonium. 🔑KEY POINTS TO REMEMBER- All volatiles: dose-dependent myocardial depression, vasodilatation, respiratory depression.
- Halothane: bradycardia, catecholamine sensitisation (arrhythmias), and halothane hepatitis (immune, repeated exposure).
- Potent volatiles (+ suxamethonium) trigger malignant hyperthermia → dantrolene; N₂O/IV agents don’t.
- Susceptible patients need a trigger-free (TIVA) anaesthetic.
- Rising ETCO₂ + rigidity + hyperthermia on a volatile = MH until proven otherwise.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Definition
The blood–gas partition coefficient is the ratio in which an inhalational agent distributes itself between blood and gas (alveolar air) at equilibrium at body temperature. It is a measure of the agent’s solubility in blood, and it is the single most important determinant of the speed of induction and recovery.
Significance
A low coefficient (insoluble agent — desflurane 0.42, nitrous oxide 0.47, sevoflurane 0.65) means blood is quickly ‘filled’, so the alveolar and brain partial pressures rise rapidly → fast induction and recovery. A high coefficient (soluble — halothane 2.4) means blood takes up large amounts, so the alveolar partial pressure rises slowly → slow onset and offset.
💡Low blood–gas solubility = fast on and fast off. It is the solubility in blood, not potency (MAC), that determines the speed of an inhalational agent — two independent properties.Independence from Potency
A point that is easily confused is that the blood–gas coefficient (speed) and MAC (potency) are entirely separate properties: nitrous oxide, for example, is both very insoluble (fast) and very weak (high MAC), while halothane is both soluble (slow) and potent (low MAC). Knowing which property is being asked about — how quickly the agent acts, or how little of it is needed — is essential, because the two do not run together and are determined by different physicochemical characteristics.
💡Fix the idea with an image: an insoluble agent barely dissolves in blood, so the blood ‘fills up’ almost at once and the partial pressure driving the agent into the brain rises fast — hence low solubility means a fast induction and, equally, a fast wake-up.⚠️Two agents anchor the scale: desflurane (0.42) at the fast, insoluble end and halothane (2.4) at the slow, soluble end — with nitrous oxide and sevoflurane near desflurane and isoflurane in between.In Brief
In short, this one coefficient predicts both how fast the patient goes to sleep and how fast they wake up.
Low blood solubility means fast onset — counterintuitive but key. Agent Blood-gas coefficient Speed of induction Desflurane 0.42 Fastest Nitrous oxide 0.47 Very fast Sevoflurane 0.65 Fast Isoflurane 1.4 Moderate Halothane 2.4 Slow 🔑KEY POINTS TO REMEMBER- Blood–gas coefficient = distribution of agent between blood and gas at equilibrium (solubility in blood).
- Main determinant of speed of induction/recovery.
- Low (desflurane, N₂O, sevoflurane) = fast; high (halothane) = slow.
- Speed (solubility) is independent of potency (MAC).
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Second Gas Effect
The second gas effect is the acceleration of the uptake of a second gas (a volatile agent) when it is given together with a high concentration of a rapidly-absorbed first gas (nitrous oxide). As large volumes of N₂O are rapidly taken up from the alveoli, the remaining alveolar gases (including the volatile agent) are concentrated, and extra gas is drawn in — speeding the rise of the volatile’s alveolar concentration and hence induction.
Diffusion Hypoxia
Diffusion hypoxia occurs at the end of a nitrous-oxide anaesthetic: when N₂O is discontinued, the large store in the blood floods back out into the alveoli, diluting the alveolar oxygen (and CO₂) and causing transient hypoxaemia. It is prevented by giving 100% oxygen for a few minutes at the end of anaesthesia.
💡Both effects stem from nitrous oxide’s large, rapid gas movements: at the start its rapid uptake concentrates the second gas (second gas effect); at the end its rapid outpouring dilutes alveolar oxygen (diffusion hypoxia — give 100% O₂).Clinical Importance
These two effects have direct practical consequences. The second gas effect is exploited to speed a gaseous induction by delivering a high concentration of nitrous oxide alongside the volatile agent, giving a smoother, quicker loss of consciousness; and diffusion hypoxia is routinely prevented by administering a high concentration of oxygen for the first few minutes after nitrous oxide is discontinued, which is why oxygen is continued into the recovery period rather than allowing the patient to breathe room air immediately.
💡Tie the two together by timing: the second gas effect helps at the beginning (nitrous oxide’s rapid uptake concentrates and speeds the volatile), while diffusion hypoxia threatens at the end (its rapid outpouring dilutes alveolar oxygen) — which is why oxygen is given for a few minutes after stopping nitrous oxide.⚠️The neat symmetry to quote is that nitrous oxide’s large, rapid movements help you in and hurt you out: aiding a quick induction at the start and threatening hypoxia at the end unless oxygen is given.Give 100% oxygen for several minutes after stopping nitrous oxide. 🔑KEY POINTS TO REMEMBER- Second gas effect: rapid N₂O uptake concentrates & speeds uptake of a co-given volatile (faster induction).
- Diffusion hypoxia: on stopping N₂O it floods into alveoli, diluting O₂ → transient hypoxaemia.
- Prevent diffusion hypoxia with 100% O₂ at the end.
- Both arise from nitrous oxide’s large, rapid alveolar gas movements.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Properties
Sevoflurane is a fluorinated volatile agent that is non-irritant and pleasant to breathe, with a low blood–gas solubility (0.65) giving rapid onset and offset and a MAC of ~2%. These properties make it the agent of choice for inhalational (gaseous) induction, particularly in children and in patients where intravenous access is difficult or a difficult airway is anticipated.
Uses & Effects
It is used for both induction and maintenance. It causes dose-dependent cardiovascular and respiratory depression but little arrhythmia and is generally well tolerated. It undergoes some metabolism, and it can react with dry CO₂ absorbent to form ‘compound A’ (of theoretical nephrotoxic concern, minimised by adequate fresh gas flows and moist absorbent).
💡Sevoflurane = the inhalational-induction agent: non-irritant, sweet-smelling and of low solubility, giving a smooth, rapid gaseous induction where an intravenous technique is unsuitable.Comparison & Role
Compared with the older agents, sevoflurane offers the smooth, non-pungent induction that halothane once provided but with far less arrhythmogenicity and a lower solubility that gives quicker control and recovery, and without halothane’s hepatotoxic reputation. Its main practical niches are therefore inhalational induction — where its lack of airway irritation is decisive — and everyday maintenance, and its chief theoretical drawback, the formation of compound A with dry absorbent, is readily managed by avoiding very low flows through desiccated soda lime.
💡In one line: sevoflurane is the agent you can safely ask a frightened child to breathe — sweet-smelling and non-irritant, with a low solubility that lets you deepen and lighten anaesthesia quickly.⚠️Its low solubility gives another practical benefit — depth can be changed quickly during the case and recovery is prompt — so sevoflurane suits day-case surgery as well as inhalational induction.In Brief
That combination of safety in induction and speed in recovery is why it has become the default volatile agent in much of everyday practice.
Agent of choice for gas induction in children. 🔑KEY POINTS TO REMEMBER- Sevoflurane: non-irritant, low solubility (fast), MAC ~2%.
- Agent of choice for inhalational induction (children, difficult access/airway) and for maintenance.
- Dose-dependent CVS/RS depression, little arrhythmia.
- Can form ‘compound A’ with dry absorbent — use adequate flows/moist soda lime.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Definition
Halothane hepatitis is a rare but potentially fatal, immune-mediated hepatic necrosis occurring after exposure to halothane. A milder, common, transient rise in liver enzymes also occurs, but the feared entity is the severe fulminant hepatitis.
Mechanism & Risk Factors
It is thought to result from an immune (hypersensitivity) reaction to oxidative metabolites of halothane (trifluoroacetyl compounds) that bind liver proteins and become antigenic. Risk factors: repeated exposure to halothane over a short interval, middle-aged obese women, and a previous unexplained reaction to halothane. It typically presents with fever and jaundice several days after anaesthesia with markedly raised transaminases.
⚠️Do not re-expose a patient to halothane within a short interval, or at all after a previous unexplained postoperative jaundice/pyrexia following halothane — repeat exposure greatly increases the risk of fatal hepatitis. Use an alternative agent.Diagnosis & Prevention
The diagnosis of halothane hepatitis is essentially one of exclusion, made when severe hepatitis follows halothane exposure with no other cause found, and it is supported by the typical picture of fever and jaundice appearing several days postoperatively, often after a repeat exposure. Prevention rests entirely on avoiding the circumstances that provoke it — not repeating halothane within a short interval, never giving it again after an unexplained reaction, and, in modern practice, simply using the newer agents, which lack this association — so the condition is now largely of historical and examination interest.
💡The safe rule is absolute: after any unexplained jaundice or fever following halothane, the drug is never given again, and in any case it is not repeated within a short interval — a precaution now made easy by the availability of the newer, non-hepatotoxic agents.⚠️Because the reaction is immune and idiosyncratic rather than dose-related, even a small repeat exposure can be dangerous, which is why the history of a previous reaction is sought and acted upon absolutely.Repeat exposure within 3 months is the main risk factor. 🔑KEY POINTS TO REMEMBER- Rare, potentially fatal immune-mediated hepatic necrosis after halothane.
- Immune reaction to oxidative (trifluoroacetyl) metabolites binding liver proteins.
- Risk: repeated exposure over a short interval, obese middle-aged women, previous reaction.
- Fever + jaundice days after anaesthesia; never re-expose — use another agent.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Definition
Entonox is a ready-mixed 50:50 mixture of nitrous oxide and oxygen in a single cylinder, used as an inhaled analgesic. It provides analgesia with retained consciousness and is self-administered by the patient through a demand valve.
Uses & Cautions
It is widely used for analgesia in labour, in ambulances and emergency departments, and for short painful procedures (dressing changes, manipulations). Its advantages are a rapid onset and offset, patient control, and the guaranteed 50% oxygen. As it contains nitrous oxide, it is avoided where N₂O is contraindicated (pneumothorax, bowel obstruction, air embolism, decompression sickness, middle-ear disease), and prolonged use carries the vitamin-B₁₂ risk. The cylinder must be kept above a certain temperature to prevent the gases separating (lamination).
💡Entonox = 50% N₂O + 50% O₂, self-administered for rapid, controllable analgesia (labour, ambulances, procedures) — but it carries all the contraindications of nitrous oxide, chiefly closed air spaces.Practical Points
In use, Entonox is patient-controlled: the patient holds the mask or mouthpiece and triggers a demand valve, which provides a built-in safety feature, since an over-sedated patient drops the mask and stops inhaling. Its rapid onset and offset suit intermittent pain such as contractions or a brief procedure, but it takes a minute or so of breathing to become effective, so it is started a little ahead of an anticipated painful moment, and it is stored and used above its pseudocritical temperature to keep the two gases mixed.
💡Think of Entonox as ‘nitrous oxide in a bottle, at a safe oxygen concentration’: excellent for rapid, self-controlled analgesia, but carrying every one of nitrous oxide’s contraindications, above all the presence of a closed air space such as a pneumothorax.⚠️A safety feature worth stating is that Entonox is self-administered: if the patient becomes drowsy they release the mask and stop inhaling, so the technique is inherently self-limiting when used as intended.Lamination separation below −6°C — store and transport above it. 🔑KEY POINTS TO REMEMBER- Entonox = 50:50 nitrous oxide/oxygen; self-administered inhaled analgesic (conscious).
- Uses: labour analgesia, pre-hospital/ED, short painful procedures; rapid on/off.
- Contraindicated wherever N₂O is (pneumothorax, bowel obstruction, air embolism, middle-ear, decompression sickness).
- Keep cylinder warm to prevent gas separation (lamination).
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Definition
The concentration effect describes how the higher the inspired concentration of an inhalational agent, the faster its alveolar concentration rises towards the inspired value (F_A/F_I rises more quickly). It is most relevant to nitrous oxide, which is given in high concentrations.
Mechanism
When a gas is present at high concentration and is rapidly taken up from the alveoli, two things speed the rise of its alveolar concentration: the concentrating effect of the shrinking alveolar gas volume as the agent is absorbed, and an augmented inflow of fresh gas drawn in to replace the absorbed volume. The same rapid uptake of a high-concentration first gas underlies the second gas effect on a co-administered agent.
💡The concentration and second-gas effects are two faces of the same phenomenon — the rapid uptake of a high concentration of nitrous oxide speeds the rise of both its own and a co-administered agent’s alveolar concentration.Relation to Nitrous Oxide
The concentration effect is chiefly of practical importance for nitrous oxide because only nitrous oxide is administered in the very high concentrations needed to make the effect significant; the potent volatile agents are given in concentrations of only a few per cent, at which the effect is negligible. This is why nitrous oxide, despite being a weak anaesthetic, contributes so usefully to the speed of a gaseous induction, both through its own rapidly-rising concentration and through the second gas effect it exerts on the accompanying volatile agent.
💡Remember that the concentration effect matters only for nitrous oxide, because only it is given in high enough concentrations to make the effect appreciable — the potent volatiles are delivered at a few per cent, where it is negligible.⚠️Keep it linked to the second gas effect in your answer: both are consequences of the rapid uptake of a high concentration of nitrous oxide, one accelerating nitrous oxide’s own rise and the other that of a co-administered agent.In Brief
So although the effect is a general principle of uptake, in the clinic it is essentially a nitrous-oxide phenomenon.
Only clinically relevant for nitrous oxide, given in high concentration. 🔑KEY POINTS TO REMEMBER- Concentration effect: higher inspired concentration → faster rise of alveolar concentration (F_A/F_I).
- Due to concentration of shrinking alveolar gas + augmented inflow as agent is absorbed.
- Most relevant to high-concentration nitrous oxide.
- Closely related to the second gas effect.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.Concept
An ideal inhalational anaesthetic agent is a theoretical benchmark against which real agents are judged. No single agent meets all the criteria, so each is a compromise — but the list explains why newer agents (sevoflurane, desflurane) replaced older ones.
Desirable Properties
Physical: stable, non-flammable, long shelf-life, cheap, environmentally friendly, easy to vaporise. Pharmacokinetic: low blood–gas solubility (rapid onset/offset), adequate potency (allowing a high inspired oxygen), and minimal metabolism. Pharmacodynamic: non-irritant and pleasant to inhale (smooth induction), with minimal cardiovascular and respiratory depression, good analgesia and muscle relaxation, no organ toxicity, and no triggering of malignant hyperthermia.
💡Summarise the ideal agent as rapid, potent, non-irritant, stable, safe and cheap — no agent achieves all of these, which is why agent choice is always a trade-off for the particular patient and procedure.Why No Agent Is Ideal
The value of the ideal-agent concept is that it exposes the trade-offs inherent in every real agent: desflurane comes closest on speed but is pungent and environmentally damaging; sevoflurane is non-irritant and quick but forms compound A and is costly; halothane is potent and smooth but slow, arrhythmogenic and hepatotoxic; and nitrous oxide is a useful analgesic adjunct but weak and hazardous around air spaces. Recognising these compromises is what allows a rational choice of agent tailored to the individual patient and the particular operation.
💡Use the ideal-agent checklist as a way to critique any real agent: ask whether it is fast, potent, non-irritant, stable, safe to the organs and free of the malignant-hyperthermia trigger — and the gaps you find explain exactly why agent choice is always a compromise.⚠️A tidy closing line: because no agent is simultaneously fast, potent, non-irritant, stable, organ-safe and free of the malignant-hyperthermia trigger, the anaesthetist chooses the agent whose compromises best suit the individual patient and operation.No single agent fulfils all criteria. Category Desired property Physical Stable, non-flammable, cheap, no soda lime reaction Pharmacokinetic Low blood-gas solubility — rapid onset and offset Pharmacodynamic Potent, good muscle relaxation, analgesic Safety Non-irritant, non-toxic, no metabolism, minimal cardiorespiratory depression 🔑KEY POINTS TO REMEMBER- Ideal agent = theoretical benchmark; every real agent is a compromise.
- Physical: stable, non-flammable, cheap, easily vaporised, environmentally friendly.
- Kinetic: low blood–gas solubility (fast), potent, minimal metabolism.
- Dynamic: non-irritant, minimal CVS/RS depression, no organ toxicity, no MH trigger.
📚SOURCES: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.